Insiders · TAK

TAK insider transactions

Takeda Pharmaceutical Company Limited (TAK) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

TAK insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Takeda Pharmaceutical Company Limited, latest first. Follow anyone to get their next filing.

• Giles Richard PlatfordPresident, IBU-$1.69M
• Teresa Marie BitettiPresident, OBU-$1.83M
• Lauren Rusckowski DupreyChief Transformation Officer, since March 2026-$1.45M
• Andrew Stewart PlumpPresident, R&D, Director-$5.34M
• Greenway Nicola Deidre PetalChief Human Resources Officer, since April 2026-$957K
• Rhonda Janice PachecoPresident, U.S. Business Unit-$289K
• Ibrahim Ramy Riad AhmedPresident, PDT BU, since April 2026-$124K
• Farajallah Awny Samaan BotrosChief Medical Officer, since April 2026-$240K
• Agosti Marcello PignagnoliHead, Strat. & Port. Dev-$393K
• Elaine Mary ShannonPres., Global Supply & Quality-$425K
• Gabriele RicciChief Data & Tech. Officer-$429K
• Julie So-Young KimPresident and CEO, Director, since March 2026-$1.52M
• Furney Natalie Anne MarieGlobal General Counsel, since March 2026-$528K
• Steven GillisDirector
• John MaraganoreDirector
• Kimberly A. ReedDirector, since March 2026
• Masami IijimaDirector
• Bruce D BroussardDirector, since June 2026
• Paulus StoffelsDirector, since June 2026
• Koichiro KimuraDirector, since June 2026
• Miki TsusakaDirector
• Asuka MiyabashiraPresident, Japan Pharma B.U., since March 2026
• Milano FurutaChief Financial Officer, Director
• Jennifer Marie SmoterChief Comm. & Gov. Officer, since April 2026
• Christophe Pierre WeberPresident and CEO, Director
• Yoshiaki FujimoriDirector, since March 2026
• Jean Luc ButelDirector, since March 2026
• Thomas WozniewskiOfficer
• Ramona SequeiraInsider
• Akiko AmakawaOfficer
• Takeda Pharmaceutical Co Ltd10% owner, since October 2021

Recent Form 3, 4, and 5 filings for TAK

• 3d
  President, IBU Platford Giles Richard sold $1,162,395 worth of American Depositary Shares (55,617 units at $20.90), decreasing direct ownership by 17% to 270,253 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 4d
  President, OBU Bitetti Teresa Marie sold $973,662 worth of American Depositary Shares (46,609 units at $20.89), decreasing direct ownership by 18% to 214,501 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 54d
  Chief Transformation Officer Duprey Lauren Rusckowski sold $640,279 worth of American Depositary Shares (34,535 units at $18.54), decreasing direct ownership by 15% to 191,522 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 66d
  President, R&D Plump Andrew Stewart sold $2,148,372 worth of American Depositary Shares (116,191 units at $18.49) as part of a pre-agreed trading plan (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 79d
  President, R&D Plump Andrew Stewart sold $363,347 worth of American Depositary Shares (19,651 units at $18.49) as part of a pre-agreed trading plan (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 81d
  Chief Human Resources Officer Greenway Nicola Deidre Petal sold $235,118 worth of American Depositary Shares (12,980 units at $18.11), decreasing direct ownership by 24% to 40,049 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  Chief Medical Officer Farajallah Awny Samaan Botros sold $239,503 worth of American Depositary Shares (14,006 units at $17.10), decreasing direct ownership by 11% to 116,177 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  President, PDT BU Ibrahim Ramy Riad Ahmed sold $124,437 worth of American Depositary Shares (7,277 units at $17.10), decreasing direct ownership by 7% to 102,588 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  President, U.S. Business Unit Pacheco Rhonda Janice sold $289,007 worth of American Depositary Shares (16,901 units at $17.10), decreasing direct ownership by 8% to 182,507 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  Chief Transformation Officer Duprey Lauren Rusckowski sold $813,721 worth of American Depositary Shares (47,586 units at $17.10), decreasing direct ownership by 17% to 226,057 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  President, R&D Plump Andrew Stewart sold $2,828,220 worth of American Depositary Shares (165,393 units at $17.10), decreasing direct ownership by 18% to 766,569 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  Head, Strat. & Port. Dev Pignagnoli Agosti Marcello sold $392,565 worth of American Depositary Shares (22,957 units at $17.10), decreasing direct ownership by 11% to 176,977 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  President, OBU Bitetti Teresa Marie sold $855,205 worth of American Depositary Shares (50,012 units at $17.10), decreasing direct ownership by 17% to 252,010 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  Pres., Global Supply & Quality Shannon Elaine Mary sold $68,024 worth of American Depositary Shares (3,978 units at $17.10), decreasing direct ownership by 6% to 63,333 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  Chief Data & Tech. Officer Ricci Gabriele sold $429,005 worth of American Depositary Shares (25,088 units at $17.10), decreasing direct ownership by 13% to 171,654 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  Chief Human Resources Officer Greenway Nicola Deidre Petal sold $115,835 worth of American Depositary Shares (6,774 units at $17.10), decreasing direct ownership by 11% to 53,029 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  President and CEO Kim Julie So-Young sold $1,523,439 worth of American Depositary Shares (89,090 units at $17.10), decreasing direct ownership by 19% to 391,489 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  President, IBU Platford Giles Richard sold $531,519 worth of American Depositary Shares (31,083 units at $17.10), decreasing direct ownership by 9% to 315,838 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  Global General Counsel Furney Natalie Anne Marie sold $527,843 worth of American Depositary Shares (30,868 units at $17.10), decreasing direct ownership by 13% to 204,298 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  Chief Human Resources Officer Greenway Nicola Deidre Petal sold $605,778 worth of American Depositary Shares (34,603 units at $17.51), decreasing direct ownership by 37% to 59,803 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 88d
  Pres., Global Supply & Quality Shannon Elaine Mary sold $357,371 worth of American Depositary Shares (20,363 units at $17.55), decreasing direct ownership by 23% to 67,311 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Director Gillis Steven was granted 3,800 units of Ordinary Shares, increasing direct ownership by 58% to 10,400 units (SEC Form 4) to satisfy withholding obligation

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Director Maraganore John was granted 3,800 units of Ordinary Shares, increasing direct ownership by 58% to 10,400 units (SEC Form 4) (for withholding tax)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Director Reed Kimberly A. was granted 3,800 units of Ordinary Shares, increasing direct ownership by 58% to 10,400 units (SEC Form 4) (tax withholding)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Director Iijima Masami was granted 1,800 units of Ordinary Shares, increasing direct ownership by 14% to 14,601 units (SEC Form 4) to satisfy withholding tax

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Director Broussard Bruce D was granted 3,800 units of American Depositary Shares, increasing direct ownership by 478% to 4,595 units (SEC Form 4) (withholding obligation)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Director Stoffels Paulus was granted 3,800 units of Ordinary Shares (SEC Form 4) to cover withholding tax

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Director Kimura Koichiro was granted 1,800 units of Ordinary Shares (SEC Form 4) (tax liability)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Director Tsusaka Miki was granted 1,800 units of Ordinary Shares, increasing direct ownership by 28% to 8,200 units (SEC Form 4) (withholding obligation)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  President, Japan Pharma B.U. Miyabashira Asuka was granted 1,500 units of Ordinary Shares, increasing direct ownership by 50% to 4,500 units (SEC Form 4) (tax liability)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Chief Financial Officer Furuta Milano was granted 12,300 units of Ordinary Shares, increasing direct ownership by 21% to 70,200 units (SEC Form 4) (tax withholding)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  President, IBU Platford Giles Richard was granted 49,558 units of American Depositary Shares, increasing direct ownership by 17% to 346,921 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Chief Comm. & Gov. Officer Smoter Jennifer Marie was granted 18,808 units of American Depositary Shares (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  President, PDT BU Ibrahim Ramy Riad Ahmed was granted 25,078 units of American Depositary Shares, increasing direct ownership by 30% to 109,865 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Chief Human Resources Officer Greenway Nicola Deidre Petal was granted 22,570 units of American Depositary Shares, increasing direct ownership by 31% to 94,406 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Chief Medical Officer Farajallah Awny Samaan Botros was granted 17,554 units of American Depositary Shares, increasing direct ownership by 16% to 130,183 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Global General Counsel Furney Natalie Anne Marie was granted 43,886 units of American Depositary Shares, increasing direct ownership by 23% to 235,166 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  President, U.S. Business Unit Pacheco Rhonda Janice was granted 50,156 units of American Depositary Shares, increasing direct ownership by 34% to 199,408 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Head, Strat. & Port. Dev. Pignagnoli Agosti Marcello was granted 27,586 units of American Depositary Shares, increasing direct ownership by 16% to 199,934 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Chief Data & Tech. Officer Ricci Gabriele was granted 37,616 units of American Depositary Shares, increasing direct ownership by 24% to 196,742 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Pres., Global Supply & Quality Shannon Elaine Mary was granted 30,094 units of American Depositary Shares, increasing direct ownership by 52% to 87,674 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  Chief Transformation Officer Duprey Lauren Rusckowski was granted 45,140 units of American Depositary Shares, increasing direct ownership by 20% to 273,643 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  President, OBU Bitetti Teresa Marie was granted 43,886 units of American Depositary Shares, increasing direct ownership by 17% to 302,022 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  President and CEO Kim Julie So-Young was granted 50,434 units of American Depositary Shares and was granted 22,800 units of Ordinary Shares, decreasing direct ownership by 95% to 22,800 units (SEC Form 4) to satisfy withholding obligation

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  President, R&D Plump Andrew Stewart was granted 125,390 units of American Depositary Shares, increasing direct ownership by 16% to 931,962 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  SEC Form 3 filed by new insider Kimura Koichiro

  3 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  New insider Broussard Bruce D claimed ownership of 795 units of American Depositary Shares (SEC Form 3)

  3 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 125d
  SEC Form 3 filed by new insider Stoffels Paulus

  3 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 188d
  SEC Form 3 filed by new insider Smoter Jennifer Marie

  3 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 195d
  President and CEO Weber Christophe Pierre was granted 78,900 units of Ordinary Shares and was granted 165,370 units of American Depositary Shares, decreasing direct ownership by 55% to 418,803 units (SEC Form 4) to cover taxes

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 195d
  President, R&D Plump Andrew Stewart was granted 212,470 units of American Depositary Shares, increasing direct ownership by 36% to 806,572 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 195d
  Head, Strat. & Port. Dev. Pignagnoli Agosti Marcello was granted 27,740 units of American Depositary Shares, increasing direct ownership by 19% to 172,348 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 195d
  Chief Transformation Officer Duprey Lauren Rusckowski was granted 59,990 units of American Depositary Shares, increasing direct ownership by 36% to 228,503 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 195d
  CEO - Elect Kim Julie So-Young was granted 105,416 units of American Depositary Shares, increasing direct ownership by 32% to 430,145 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 195d
  Chief Data & Tech. Officer Ricci Gabriele was granted 34,994 units of American Depositary Shares, increasing direct ownership by 28% to 159,126 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 195d
  Chief Financial Officer Furuta Milano was granted 7,800 units of Ordinary Shares, increasing direct ownership by 16% to 57,900 units (SEC Form 4) (withholding obligation)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 195d
  President, OBU Bitetti Teresa Marie was granted 64,988 units of American Depositary Shares, increasing direct ownership by 34% to 258,136 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 195d
  President, IBU Platford Giles Richard was granted 72,124 units of American Depositary Shares, increasing direct ownership by 32% to 297,363 units (SEC Form 4)

  4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 217d
  SEC Form 3 filed by new insider Greenway Nicola Deidre Petal

  3 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
• 217d
  SEC Form 3 filed by new insider Farajallah Awny Samaan Botros

  3 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)